What an NPN Does — and Doesn't — Tell You About Dose

A Natural Product Number is a real regulatory signal. To get one, a company has to satisfy Health Canada — before selling anything — that the product is safe, made to quality standards, and that its claims are supported. That is genuinely more front-loaded than the American system, and it is a reasonable thing to look for on a label.

But an NPN answers a narrower question than most buyers think. It tells you a product is permitted to make a specific claim. It does not tell you that the amount inside matches the amount used in the research that made the ingredient interesting. Those are two separate tests, and a product can pass the first while sitting at the bottom of the second.

Why a licensed dose can sit below a studied dose

Health Canada publishes ingredient monographs — pre-set documents defining the dose ranges and exact claim wording a product can use without submitting its own evidence. Staying inside a monograph is the fast, clean path to a licence. The thing to understand is that a product only has to clear the bottom of the permitted range to earn the claim, and that bottom can sit anywhere relative to the doses trials actually used: at them, below them, or in the middle of them. The licence does not distinguish between those cases.

The result is a product that is fully licensed, entirely legal, accurately labelled — and still at the floor of what was studied. Nothing about that is deceptive in a regulatory sense. It is simply a different question from the one you are probably asking.

Our own formula, as the worked example

It would be easy to illustrate this with somebody else's product. We would rather use ours, because the point lands harder when it costs us something.

Signal State Core is a pre-launch concept, and its working formula puts citicoline at 250 mg per daily serving. Health Canada's Cognitive Function monograph permits citicoline between 250 mg and 1,000 mg per day, so our hero ingredient sits exactly on the monograph floor. That sounds like a criticism until you check the second question: the attention trial in healthy adults tested 250 mg and 500 mg, and found the effect at both. Our floor dose is also a studied dose.

Which is the whole point. "On the monograph floor" and "below what the research supports" are different statements, and only one of them is checkable from a licence. Ours happens to be the harmless case. A different product at a different monograph's floor might be nowhere near its studied range, and the NPN would look identical.

That is the honest shape of the thing. A licence tells you a floor was cleared. Only the arithmetic below tells you where in the studied range a product actually sits.

Step one: the number on the label is per dosage unit

This is the step almost everyone skips, and the one most likely to mislead you. Ingredient amounts — on labels and in Health Canada's own database — are given per dosage unit: per capsule, per tablet, per gummy, per scoop. They are not the daily total.

So the daily amount is three numbers multiplied together: the quantity per dosage unit, the number of units per intake, and how many times a day it is taken. A product listing 250 mg per capsule at two capsules twice daily delivers 1,000 mg a day, not 250. Where the directions give a range — "one to two capsules daily" — you get a range, and it is worth keeping it as a range rather than flattening it to whichever end suits the argument.

Step two: for botanicals, milligrams of what?

For an isolated compound like citicoline or L-theanine, the number is the number once you have done step one. Botanicals need more care, and two figures get confused constantly.

• The extract ratio ("25:1") describes how much raw plant went into the extract. It tells you about concentration during manufacture. It does not tell you how much of any active constituent ends up in the capsule.
• The standardization percentage ("50% bacosides", "3% rosavins") tells you how much of a named marker compound the extract is guaranteed to contain. Multiply it by the daily extract weight and you get the labelled marker content.

That second figure is genuinely useful, and it is the closest thing to an apples-to-apples comparison you can make from a label. But it carries a caveat worth taking seriously: a marker is not necessarily the active. Health Canada itself distinguishes active constituents from analytical markers that may not drive the effect. Trials study whole, defined extracts — a particular preparation, made a particular way — not a quantity of an isolated marker.

So matching a study's marker milligrams does not prove you have matched the study's extract. It is a reasonable sanity check and a poor equivalence proof. Anyone claiming their botanical is "clinically dosed" purely because a percentage multiplies out is overselling the arithmetic — including us, if we ever do it.

A field that looks useful and mostly isn't: market status

Each database record also carries a market status, and it is tempting to read it as whether you can buy the thing. Treat it as non-conclusive. Health Canada's guidance is explicit that notifying them a product has gone on sale is voluntary, that a licence holder "is not required to wait for the LNHPD to be updated before a licensed product is sold in Canada," and that products identified as "not marketed" may still be sold here.

Holders can and do submit availability updates, so the field is not meaningless — it is just unreliable as a yes-or-no answer. If you want to know whether something is actually purchasable, check retailers, not the licence database.

How to check any product yourself

This takes a few minutes and works for any natural health product sold in Canada. It is the most useful habit you can build as a supplement buyer here.

• Find the eight-digit NPN on the label, or search the product in Health Canada's Licensed Natural Health Products Database.
• Read the medicinal ingredients list. Quantities are published for most records, including many whose own marketing is vague — though some entries defer to the monograph rather than stating a figure, in which case the label itself is your source.
• Multiply: quantity per dosage unit, times units per intake, times daily frequency. Keep ranges as ranges.
• For botanicals, note the extract ratio and standardization percentage and work out the labelled marker content — while remembering it is a marker, not proof of extract equivalence.
• Compare against the doses the research actually used. Our ingredient library lists the studied range and a conservative evidence grade for each one, with the trials cited.

What an NPN is genuinely good for

None of this is an argument against caring about licensing. An NPN tells you a regulator reviewed the product's safety and quality before it was sold, that the claims on the package were checked in advance, and that there is a company on record and accountable for it. Against a product shipped in from another market with no Canadian review behind it, that is a meaningful difference.

Just treat it as the floor rather than the ceiling. An NPN is evidence that a product cleared a safety and claims review. Where it sits within the studied range is a separate question, it is entirely public, and it is the one that decides whether what you are buying resembles what was tested. Ask both.

• Licensed means reviewed for safety, quality, and permitted claims — before sale.
• Licensed does not mean the dose matches the research; monograph minimums often sit at the bottom of the studied range, or below it.
• Label amounts are per dosage unit. Multiply by units per intake and daily frequency before comparing anything to anything.
• For botanicals, the standardization percentage gives marker content — useful, but not proof of extract equivalence.
• Market status is not conclusive evidence of availability either way. Check retailers instead.

Sources

• Health Canada, Licensed Natural Health Products Database (LNHPD) — product licence records and medicinal ingredient panels: health-products.canada.ca/lnhpd-bdpsnh/
• Health Canada, LNHPD — on market status: "market notification is voluntary; therefore, a licence holder is not required to wait for the LNHPD to be updated before a licensed product is sold in Canada," and products identified as "not marketed" may still be sold in Canada.
• Health Canada, Natural and Non-prescription Health Products Directorate — Compendium of Monographs, including the Cognitive Function Products monograph (permitted dose ranges and claim wording), and quality guidance distinguishing active constituents from analytical markers.
• McGlade E, Locatelli A, Hardy J, et al. "Improved attentional performance following citicoline administration in healthy adult women." Food and Nutrition Sciences, 2012;3(6):769–773. (250 mg and 500 mg daily.)
• Calabrese C, Gregory WL, Leo M, et al. "Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly." Journal of Alternative and Complementary Medicine, 2008;14(6):707–713. PMID: 18611150. (300 mg daily of a standardized extract.)
• Darbinyan V, Kteyan A, Panossian A, et al. "Rhodiola rosea in stress induced fatigue." Phytomedicine, 2000;7(5):365–371. PMID: 11081987. (170 mg daily, SHR-5 extract.)
• Spasov AA, Wikman GK, Mandrikov VB, et al. "A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea." Phytomedicine, 2000;7(2):85–89. PMID: 10839209. (100 mg daily, SHR-5 extract.)
• Nobre AC, Rao A, Owen GN. "L-theanine, a natural constituent in tea, and its effect on mental state." Asia Pacific Journal of Clinical Nutrition, 2008;17(S1):167–168. PMID: 18296328. (50 mg.)
• Haskell CF, Kennedy DO, Milne AL, Wesnes KA, Scholey AB. "The effects of L-theanine, caffeine and their combination on cognition and mood." Biological Psychology, 2008;77(2):113–122. PMID: 18006208. (250 mg.)